In conclusion, in this study, we show that PTK6 protein expression in 426 breast cancer cases is of high prognostic value, independent of the classical morphological and molecular markers, such as lymph node involvement, tumour size, and HER2 status. This evidence concerns the gene ERBB2 and neoplasm.